126 related articles for article (PubMed ID: 37660413)
1. Clinical implications of histologic subtypes on survival outcomes in primary mucinous ovarian carcinoma.
Lim H; Ju Y; Kim SI; Park JH; Kim HS; Chung HH; Kim JW; Park NH; Song YS; Lee C; Lee M
Gynecol Oncol; 2023 Oct; 177():117-124. PubMed ID: 37660413
[TBL] [Abstract][Full Text] [Related]
2. Results of Fertility-Sparing Surgery for Expansile and Infiltrative Mucinous Ovarian Cancers.
Gouy S; Saidani M; Maulard A; Bach-Hamba S; Bentivegna E; Leary A; Pautier P; Devouassoux-Shisheboran M; Genestie C; Morice P
Oncologist; 2018 Mar; 23(3):324-327. PubMed ID: 29242280
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of patients with early stage mucinous ovarian carcinoma: a Dutch population-based cohort study comparing expansile and infiltrative subtypes.
Algera MD; Van de Vijver KK; van Driel WJ; Slangen BFM; Lof FC; van der Aa M; Kruitwagen RFPM; Lok CAR
Int J Gynecol Cancer; 2024 May; 34(5):722-729. PubMed ID: 38460968
[TBL] [Abstract][Full Text] [Related]
4. Survival and biomarker analysis for ovarian mucinous carcinoma according to invasive patterns: retrospective analysis and review literature.
Hada T; Miyamoto M; Ishibashi H; Matsuura H; Sakamoto T; Kakimoto S; Iwahashi H; Tsuda H; Takano M
J Ovarian Res; 2021 Feb; 14(1):33. PubMed ID: 33583413
[TBL] [Abstract][Full Text] [Related]
5. Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation.
Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; D'argent Mathieu E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101966. PubMed ID: 33144266
[TBL] [Abstract][Full Text] [Related]
6. The clinicopathological characteristics and survival outcomes of primary expansile
Nistor S; El-Tawab S; Wong F; Zouridis A; Roux R; Manek S; Gaitskell K; Ahmed AA; Kehoe S; Soleymani Majd H
Transl Cancer Res; 2023 Oct; 12(10):2682-2692. PubMed ID: 37969399
[TBL] [Abstract][Full Text] [Related]
7. Prognostic similarity between ovarian mucinous carcinoma with expansile invasion and ovarian mucinous borderline tumor: A retrospective analysis.
Hada T; Miyamoto M; Ishibashi H; Matsuura H; Sakamoto T; Kakimoto S; Iwahashi H; Suzuki R; Sato K; Tsuda H; Takano M
Medicine (Baltimore); 2021 Aug; 100(32):e26895. PubMed ID: 34397915
[TBL] [Abstract][Full Text] [Related]
8. Comparison of clinical behavior between mucinous ovarian carcinoma with infiltrative and expansile invasion and high-grade serous ovarian carcinoma: a retrospective analysis.
Hada T; Miyamoto M; Ishibashi H; Matsuura H; Kakimoto S; Iwahashi H; Tsuda H; Takano M
Diagn Pathol; 2022 Jan; 17(1):12. PubMed ID: 35057833
[TBL] [Abstract][Full Text] [Related]
9. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.
Fang C; Zhao L; Chen X; Yu A; Xia L; Zhang P
BMC Cancer; 2018 Nov; 18(1):1147. PubMed ID: 30463533
[TBL] [Abstract][Full Text] [Related]
10. International Study of Primary Mucinous Ovarian Carcinomas Managed at Tertiary Medical Centers.
Mueller JJ; Lajer H; Mosgaard BJ; Bach Hamba S; Morice P; Gouy S; Hussein Y; Soslow RA; Schlappe BA; Zhou QC; Iasonos A; Høgdall C; Leary A; O'Cearbhaill RE; Abu-Rustum NR
Int J Gynecol Cancer; 2018 Jun; 28(5):915-924. PubMed ID: 29561302
[TBL] [Abstract][Full Text] [Related]
11. Comparison of long-term oncologic outcomes between metastatic ovarian carcinoma originating from gastrointestinal organs and advanced mucinous ovarian carcinoma.
Kajiyama H; Suzuki S; Utsumi F; Yoshikawa N; Nishino K; Ikeda Y; Niimi K; Yamamoto E; Kawai M; Shibata K; Nagasaka T; Kikkawa F
Int J Clin Oncol; 2019 Aug; 24(8):950-956. PubMed ID: 30941534
[TBL] [Abstract][Full Text] [Related]
12. Staging surgery in early-stage ovarian mucinous tumors according to expansile and infiltrative types.
Gouy S; Saidani M; Maulard A; Faron M; Bach-Hamba S; Bentivegna E; Leary A; Pautier P; Devouassoux-Shisheboran M; Genestie C; Morice P
Gynecol Oncol Rep; 2017 Nov; 22():21-25. PubMed ID: 28971140
[TBL] [Abstract][Full Text] [Related]
13. An Analysis of Prognostic Factors in Patients with Ovarian Malignant Germ Cell Tumors Who Are Treated with Fertility-Preserving Surgery.
Yang ZJ; Liu ZC; Wei RJ; Li L
Gynecol Obstet Invest; 2016; 81(1):1-9. PubMed ID: 25967958
[TBL] [Abstract][Full Text] [Related]
14. Characteristics and Prognosis of Stage I Ovarian Mucinous Tumors According to Expansile or Infiltrative Type.
Gouy S; Saidani M; Maulard A; Bach-Hamba S; Bentivegna E; Leary A; Pautier P; Devouassoux-Shisheboran M; Genestie C; Morice P
Int J Gynecol Cancer; 2018 Mar; 28(3):493-499. PubMed ID: 29466254
[TBL] [Abstract][Full Text] [Related]
15. Recurrence-predicting prognostic factors for patients with early-stage epithelial ovarian cancer undergoing fertility-sparing surgery: a multi-institutional study.
Kajiyama H; Mizuno M; Shibata K; Yamamoto E; Kawai M; Nagasaka T; Kikkawa F
Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():97-102. PubMed ID: 24507757
[TBL] [Abstract][Full Text] [Related]
16. Prognosis in primary mucinous ovarian carcinoma: focusing on the five pathological findings indicating metastatic mucinous carcinoma to the ovary.
Lee SW; Sung JA; Jung M; Kim H; Lee C
J Gynecol Oncol; 2022 Mar; 33(2):e18. PubMed ID: 34910399
[TBL] [Abstract][Full Text] [Related]
17. Histological classification of mucinous ovarian tumors: inter-observer reproducibility, clinical relevance, and role of genetic biomarkers.
Genestie C; Auguste A; Al Battal M; Scoazec JY; Gouy S; Lacroix L; Morice P; Pautier P; Leary A; Devouassoux-Shisheboran M
Virchows Arch; 2021 May; 478(5):885-891. PubMed ID: 33009577
[TBL] [Abstract][Full Text] [Related]
18. Oncological and Reproductive Outcomes After Fertility-Sparing Surgery for Stage I Mucinous Ovarian Carcinoma.
Lin W; Cao D; Shi X; You Y; Yang J; Shen K
Front Oncol; 2022; 12():856818. PubMed ID: 35860580
[TBL] [Abstract][Full Text] [Related]
19. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
[TBL] [Abstract][Full Text] [Related]
20. Fertility-Sparing Surgery in Infiltrative Mucinous Carcinoma of the Ovary.
Ben Ltaief S; Ghalleb M; Chabchoub A; Slimen M; Hadj Kacem L; Zenzeri Y; Chargui R; Dhieb T
Case Rep Oncol; 2023; 16(1):1494-1499. PubMed ID: 38033415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
